๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents

โœ Scribed by Kemp, Roslyn; Dunn, Elliott; Schultz, Michael

Book ID
120481087
Publisher
Springer International Publishing AG
Year
2013
Tongue
English
Weight
258 KB
Volume
27
Category
Article
ISSN
1173-8804

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Stopping immunomodulators and biologics
Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission
โœ Kofi Clarke; Miguel Regueiro ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB

The emergence of biologic response modifiers and earlier use of immunomodulators for inflammatory bowel disease (IBD) patients have improved outcomes. Durable remissions have been achieved in many IBD patients on these treatments, but the duration of treatment and identifying which patients may stop

Vaccination strategies for patients with
Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
โœ Gil Y. Melmed ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB ๐Ÿ‘ 1 views

The treatment of Crohn's disease and ulcerative colitis frequently includes potent immunomodulator and biologic therapy to reduce intestinal inflammation, heal fistulae, limit complications, and improve quality of life. These medications may increase susceptibility to and severity of infections, man